67 Comments
 

Here's YTD M&A league tables from Thomson Reuters/Refinitiv.

Edit: Since the picture isn't showing up:

1. Goldman Sachs - $412.0 bn, 131 Deals

2. JP Morgan - $250.6 bn, 94 Deals

3. Morgan Stanley - $221.3 bn, 97 Deals

4. BofA - $197.4 bn, 69 Deals

5. Citi - $182.5 bn, 52 Deals

6. Barclays - $119.7 bn, 66 Deals

7. Credit Suisse - $116.2 bn, 39 Deals

8. Jefferies - $101.1 bn, 71 Deals

9. BNP Paribas - $95.8 bn, 36 Deals

10. Lazard - $89.9 bn, 69 Deals

 

Balance sheet bank. Gets buy-side advisory credit on a number of large deals each year for providing cheap financing (large deals they got buy-side credit for providing financing that I can think of this year include the HDFC and Cornerstone deals). Almost always the buy-side advisor for their larger deals, and usually not the sole bank (because they are mainly just there to provide financing while another bank does the advisory).

 

From Thomson Reuters/Refinitiv. Obviously not perfect (some deals are classed incorrectly, and had to manually de-select gaming and media & telecom), but a solid approximation :

1. JP Morgan - $17.7 bn, 12 Deals

2. GS - $16.7 bn, 10 Deals

3. Citi - $14.0 bn, 7 Deals

4. Jefferies - $11.9 bn, 4 Deals

5. BofA - $10.7 bn, 10 Deals

6. Rothschild - $9.2 bn, 16 Deals

7. MS - $6.2 bn, 9 Deals

8. Evercore - $3.6 bn, 5 Deals

9. Barclays - $3.6 bn, 9 Deals

10. Arctic Securities - $3.2 bn, 1 Deal

 

From Thomson Reuters for TMT:

1. GS - $165.1 bn, 42 Deals

2. Allen & Co - $84.5 bn, 3 Deals

3. JP Morgan - $55.8 bn, 25 Deals

4. Citi - $38.4 bn, 5 Deals

5. BofA - $37.5 bn, 11 Deals

6. Barclays - $36.5 bn, 9 Deals

7. MS - $35.9 bn, 22 Deals

8. CS - $33.4 bn, 7 Deals

9. Qatalyst - $27.6 bn, 3 Deals

10. PJT Partners - $20.8 bn, 9 Deals

GS dominating the TMT space as per usual.

 

From the poster below: 
 

League tables don't include HCIT, which are usually classified under Technology, so the league tables for HC are more like BioTech + HC Services + Med Devices.

1. SVB Leerink - $8.6 bn, 4 Deals

2. Jefferies - $7.9 bn, 14 Deals

3. Citi - $6.1 bn, 5 Deals

4. JP Morgan - $4.0 bn, 8 Deals

5. Lazard - $4.0 bn, 11 Deals

6. Evercore - $3.6 bn, 4 Deals

7. Moelis - $3.5 bn, 6 Deals

8. Allegro Capital Advisors - $3.3 bn, 1 Deal

8. PJT Partners - $3.3 bn, 1 Deal

10. GS - $3.2 bn, 10 Deals

SVBL and Jefferies leading the pack, SVB with a fast start in BioTech and Jefferies doing their usual thing in HC Services and BioTech, and both landing the LHC/Optum deal. Also, not reflected in the top 10 league tables are MS executing a bunch of services & biotech deals with undisclosed values (Over a dozen deals to date), and HL and Rothschild doing quite some volume in the MM space.

 
Most Helpful

From Factset, which tends to miss quite a number of deals. Also should note that O&G league tables aren't the best because a lot of sizable O&G deals A&D deals are undisclosed and aren't included (which are Rothschild and JEF especially do quite a lot of):

1. RBC - $10.5 bn, 10 Deals

2. Citigroup - $5.7 bn, 3 Deals

3. Jefferies - $3.6 bn, 5 Deals

4. PWP/TPH - $3.6 bn, 3 Deals

5. GS - $3.5 bn, 1 Deal

6. JP Morgan - $2.6 bn, 1 Deal

7. Scotiabank - $1.6 bn, 1 Deal

8. PJT Partners - $1.3 bn, 1 Deal

9. WF - $960 mm, 2 Deals

10. Johnson Rice & Co, $860 mm, 1 Deal

Overall basically what you'd expect. RBC shows its lending prowess and relationships, with 7 of its 10 deals being buy-side deals; Citi is overall strong in O&G. Jefferies is killing it in A&D (can confirm that Factset misses a number of those transactions), and PWP/TPH has made a comeback despite concerns over losing some top seniors.

 

From Thomson Reuters. Keep in mind that many RX deals are undisclosed and YTD 2022 RX activity has been pretty muted.

1. Moelis - $77.7 bn, 7 Deals

2. PJT Partners - $59.6 bn, 5 Deals

3. Lazard - $58.4 bn, 5 Deals

4. HL - $53.4 bn, 7 Deals

5. Rothschild - $38.2 bn, 3 Deals

6. Ankura Consulting Group - $35 bn, 1 Deal

7. Greenhill - $35 bn, 1 Deal

8. AlixPartners - $19.0 bn, 3 Deals

9. FTI Consulting - $17.4 bn, 2 Deals

10. Evercore - $9.7 bn, 2 Deals

 

from my understanding, RX league tables can be misleading in a way that is similar to how m&a league tables can be misleading: balance sheet banks get m&a credit for facilitating financing - one RX deal can have multiple shops repping debtor & different classes of creditors, so don’t think the tables are super indicative (+ the many undisclosed RX deals)

 

are 8 and 9 their actual IB divisions or their normal consulting divisions.

 

From Thomson Reuters, any Canadian involvement:

1. MS - $20.4 bn, 13 Deals

2. JPM - $18.5 bn, 5 Deals

3. TD - $16.6 bn, 8 Deals

4. Goldman Sachs - $10.8 bn, 8 Deals

5. Lazard - $9.9 bn, 9 Deals

6. RBC - $9.4 bn, 17 Deals

7. Credit Suisse - $7.2 bn, 5 Deals

8. Barclays - $5.7 bn, 4 Deals

9. CIBC - $5.4 bn, 8 Deals

10. PJT - $4.4 bn, 2 Deals

Basically no surprises, except for maybe the fact that BMO isn't in the top 10, but the year is still early.

 

League tables don't include HCIT, which are usually classified under Technology, so the league tables for HC are more like BioTech + HC Services + Med Devices.

1. SVB Leerink - $8.6 bn, 4 Deals

2. Jefferies - $7.9 bn, 14 Deals

3. Citi - $6.1 bn, 5 Deals

4. JP Morgan - $4.0 bn, 8 Deals

5. Lazard - $4.0 bn, 11 Deals

6. Evercore - $3.6 bn, 4 Deals

7. Moelis - $3.5 bn, 6 Deals

8. Allegro Capital Advisors - $3.3 bn, 1 Deal

8. PJT Partners - $3.3 bn, 1 Deal

10. GS - $3.2 bn, 10 Deals

SVBL and Jefferies leading the pack, SVB with a fast start in BioTech and Jefferies doing their usual thing in HC Services and BioTech, and both landing the LHC/Optum deal. Also, not reflected in the top 10 league tables are MS executing a bunch of services & biotech deals with undisclosed values (Over a dozen deals to date), and HL and Rothschild doing quite some volume in the MM space.

 
[Comment removed by mod team]
 

From Thomson Reuters, YTD 4/05/2021 league tables last year:

1. GS - $374.1 bn, 169 Deals

2. JP Morgan - $292.2 bn, 164 Deals

3. MS - $227.7 bn, 109 Deals

4. Citi - $223.3 bn, 100 Deals

5. BofA - $197.3 bn, 84 Deals

6. Barclays - $156.1 bn, 80 Deals

7. CS - $139.0 bn, 72 Deals

8. Evercore - $121.4 bn, 50 Deals

9. Lazard - $73.8 bn, 65 Deals

10. DB - $57.4 bn, 39 Deals

11. UBS - $57.2 bn, 51 Deals

12. Jefferies - $54.5 bn, 86 Deals

13. PJT - $54.2 bn, 20 Deals

14. BMO - $50 bn, 15 Deals

15. CVP - $42.6 bn, 24 Deals

Industry Total of $1.3 trillion compared with $1.1 trillion in transaction volume YTD 2022.

 

Lack of marquee transactions. By this point last year their announced deals include the $31 bn AerCap/GE deal, the $31 bn Canadian Pacific/Kansas City Southern deal, and the $8 bn Teledyne/FLIR Deal, and by this point in 2020 they had completed the $24.5 bn Otis Elevator spin-off, the $21 bn UTC spin-off, and the $11 bn Equitrans Midstream/EQM deal. Largest deal so far this year was the $9 bn TEGNA deal, and most of their announced deals have been mid-cap to UMM-sized deals.

 

1. JPM - $105.5 bn, 14 Deals

2. GS - $102.0 bn, 21 Deals

3. MS - $87.7 bn, 11 Deals

4. BofA - $79.0 bn, 14 Deals

5. Citi - $76.2 bn, 9 Deals

6. CS - $65.5 bn, 6 Deals

7. BNP Paribas - $63.5 bn, 7 Deals

8. Axis Bank - $62.6 bn, 3 Deals

9. Jefferies - $60.8 bn, 7 Deals

10. CITIC - $60.7 bn, 3 Deals

Big year for FIG with the landmark HDFC merger which half the BBs got buy-side credit for (although Jefferies and CS were the big winners from that as joint lead sell-side advisors), as well as Citi shedding their consumer bank (providing themselves with some nice deal flow lol).

 

From above:

From Factset, which tends to miss quite a number of deals. Also should note that O&G league tables aren't the best because a lot of sizable O&G deals A&D deals are undisclosed and aren't included (which are Rothschild and JEF especially do quite a lot of):

1. RBC - $10.5 bn, 10 Deals

2. Citigroup - $5.7 bn, 3 Deals

3. Jefferies - $3.6 bn, 5 Deals

4. PWP/TPH - $3.6 bn, 3 Deals

5. GS - $3.5 bn, 1 Deal

6. JP Morgan - $2.6 bn, 1 Deal

7. Scotiabank - $1.6 bn, 1 Deal

8. PJT Partners - $1.3 bn, 1 Deal

9. WF - $960 mm, 2 Deals

10. Johnson Rice & Co, $860 mm, 1 Deal

Overall basically what you'd expect. RBC shows its lending prowess and relationships, with 7 of its 10 deals being buy-side deals; Citi is overall strong in O&G. Jefferies is killing it in A&D (can confirm that Factset misses a number of those transactions), and PWP/TPH has made a comeback despite concerns over losing some top seniors.

 

Laboriosam facere et voluptatem. Et quidem dolorem vel nisi quia laudantium pariatur ea. Asperiores voluptatibus perferendis molestias qui labore asperiores quas.

Sed libero tenetur nam ratione autem fugit. Temporibus totam eos vero et itaque. Nobis non magni reprehenderit assumenda id qui.

 

Aut qui quia in recusandae. Dolorum quia fuga perspiciatis vel iure et. Nisi dignissimos ut voluptas dolor.

Maxime sit sit nihil possimus. Illo eveniet natus blanditiis a delectus. Sed assumenda soluta magni eligendi vel voluptatem.

Debitis accusantium placeat ipsam tenetur aut eligendi. Rem in et a eum. Nisi eos nihil ad est dolor ipsum nisi.

 

Ex sit vel reiciendis eos reprehenderit quasi deleniti. Omnis aperiam quia vel dicta enim in itaque hic. Quos rerum voluptatem et quis explicabo quia suscipit repudiandae. Omnis molestiae dolor sed possimus aut omnis cupiditate. Velit dolorem ut officia. Et sit eius perferendis modi facilis est.

Est sed explicabo ut. Est quia doloremque aut non. Consequatur aut aut at qui. Tempora aut maxime quasi sed voluptas in dolores qui.

Maxime rerum reiciendis architecto cum consequatur et aut. Consequatur accusamus error sunt qui ut. Et quidem nam impedit nisi sunt totam. Quis fuga aut consectetur eaque et. Rerum id est dolorum suscipit exercitationem id. Qui optio veritatis quae quia. Quisquam labore error ut in aut dolores est.

Career Advancement Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

November 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 04 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

November 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

November 2026 Investment Banking

  • Vice President (17) $409
  • Associates (58) $261
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (29) $183
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (77) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”